– Security and Reporting Issuer
The designation of securities to which this report relates and the name and address of the head office of the issuer of the securities:
IBEX Technologies Inc. (the “Issuer”) Suite 100 – 5485 Pare Street Montreal, QC H4P 1P7
The name of the market in which the transaction or other occurrence that triggered the requirement to file this report took place:
TSX Venture
– Identity of Eligible Institutional Investor
The name and address of the eligible institutional investor:
McLean Capital Inc. (“McLean Capital”) 4020 Le Corbusier, suite 200
Laval, QC H7L 5R2
The date of the transaction or other occurrence that triggered the requirement to file this report:
The requirement to file this report was triggered on May 17, 2023 when McLean Capital acquired 82,500 shares of the Issuer at an average price of $0.81.
The names of any joint actors in connection with the disclosure required by this report:
Not applicable.
A statement that the eligible institutional investor is eligible to file reports under Part 4 of National Instrument 62-103 in respect of the reporting issuer’s securities:
McLean Capital is eligible to file reports under Part 4 of National Instrument 62-103 in respect of the above securities.
– Interest in Securities of the Reporting Issuer
The designation and the net increase or decrease in the number or principal amount of securities, and in the eligible institutional investor’s security holding percentage in the class of securities, since the last report filed by the eligible institutional investor